Profile
Jeroen Rovers formerly worked at Organon NV, as Director-Clinical Development, Kiadis Pharma BV, as Chief Medical Officer from 2014 to 2015, DCPrime BV, as Chief Medical Officer from 2018 to 2020, Ceronco Biosciences, as Chief Medical Officer, and Mendus AB, as Chief Medical Officer from 2021 to 2025.
Dr. Rovers received his doctorate degree from the University of Leiden.
Former positions of Jeroen Rovers
| Companies | Position | End |
|---|---|---|
| MENDUS AB | Chief Tech/Sci/R&D Officer | 2025-05-04 |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Chief Tech/Sci/R&D Officer | 2020-11-30 |
Ceronco Biosciences | Chief Tech/Sci/R&D Officer | - |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology Develops manufactures and sells prescription medicines | Corporate Officer/Principal | - |
Kiadis Pharma BV
Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell based immunotherapy products | Chief Tech/Sci/R&D Officer | - |
Training of Jeroen Rovers
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology Develops manufactures and sells prescription medicines | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiadis Pharma BV
Kiadis Pharma BV Pharmaceuticals: MajorHealth Technology Operates as a is a clinical stage biopharmaceutical company focused on research, development and future commercialization of cell based immunotherapy products | Health Technology |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Health Technology |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Ceronco Biosciences |
- Stock Market
- Insiders
- Jeroen Rovers
















